Abstract:Background: Sulfotransferase (SULT) plays an important role in the formation of estrogen which is usually conferred as a risk factor for breast cancer. Polymorphism of the SULT1A1 may be closely associated with breast cancer. However, studies on the association between polymorphism and breast cancer have yielded inconsistent results. We performed a meta-analysis including ethnic subgroup and menopausal statue subgroup to investigate the association of SULT1A1 Arg213His polymorphism with breast cancer.Methods: PubMed, EBSCO and Web of Science databases were searched for the correlative articles up to January 2010 (10362 breast cancer patients and 14250 controls). The risk (odds ratio, OR) was used to estimate the association between SULT1A1 polymorphism and breast cancer risk. All of the data from each study use either fixed-effects or random-effects.Results: We found that SULT1A1 Arg213His had no exact effect to increase the risk of breast cancer (OR = 1.07, 95% CI: 0.97-1.17, P = 0.164), but it did increase the risk of breast cancer among postmenopausal women in the dominant model (OR = 1.28, 95% CI: 1.04-1.58, P = 0.019). No similar effect was found among premenopausal breast cancer women (OR = 1.06, 95% CI: 0.88-1.27, P = 0.537). There was a significant increase in breast cancer risk among Asian women (OR = 2.03, 95% CI: 1.00-4.14, P = 0.051) but not Caucasian women in recessive model. There was publication bias among postmenopausal women subgroup (P = 0.002), however by using the trim and fill method, if the publication bias was the only source of the funnel plot asymmetry, it needed two more studies to be symmetrical. The value of Log OR did not change too much after the adjustment and the fail-safe number of missing studies that would bring the P-value changed was 17.Conclusions: We concluded that the polymorphism of SULT1A1 Arg213His might be one of the high risk factors for breast cancer in Asian women and in postmenopausal women for all races. We should point out that the publication bias among postmenopausal women may partly account for the result, but the conclusion might not affected deeply by the publication bias.

There is No Relationship Between SOD2 Val-16Ala Polymorphism and Breast Cancer Risk or Survival.

Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects

Association Between MnSOD Val16Ala Polymorphism and Cancer Risk: Evidence from 33,098 Cases and 37,831 Controls.

Association Betweenmnsodval16ala Polymorphism and Cancer Risk: Evidence from 33,098 Cases and 37,831 Controls

Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis.

Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study

Association Between Manganese Superoxide Dismutase Gene Polymorphism and Risk of Prostate Cancer: A Meta-analysis

Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk

The interaction between polymorphisms in MnSOD and prostate cancer risk : a meta-analysis and systematic review

Mn-SOD and CuZn-SOD Polymorphisms and Interactions with Risk Factors in Gastric Cancer

Association of Sulfotransferase Sult1a1 with Breast Cancer Risk: A Meta-Analysis of Case-Control Studies with Subgroups of Ethnic and Menopausal Statue

Correlation Between Superoxide Dismutase 1 and 2 Polymorphisms and Susceptibility to Oral Squamous Cell Carcinoma

Lack of Association Between Catechol-O-methyltransferase Val108/158Met Polymorphism and Breast Cancer Risk: a Meta-Analysis of 25,627 Cases and 34,222 Controls

The Association Between Rad23b Ala249val Polymorphism and Cancer Susceptibility: Evidence from A Meta-Analysis

The Association of Sult1a1 Codon 213 Polymorphism and Breast Cancer Susceptibility: Meta-Analysis from 16 Studies Involving 23,445 Subjects

Single Nucleotide Polymorphism of Sod2 to Predict Survival for Chinese Gastric Cancer Patients Received Platinum/Fluorouracil-Based Adjuvant Chemotherapy

Association Of The Mdm2 Snp285 Polymorphism With Cancer Susceptibility: A Meta-Analysis

Lack of Association Between the Hogg1 Ser326Cys Polymorphism and Breast Cancer Risk: Evidence from 11 Case–control Studies

MnSOD Val16Ala Polymorphism and Prostate Cancer Susceptibility: a Meta-Analysis Involving 8,962 Subjects.

Two Common Functional Catalase Gene Polymorphisms (Rs1001179 And Rs794316) And Cancer Susceptibility: Evidence From 14,942 Cancer Cases And 43,285 Controls

Association Between MDM2 Rs 2279744 Polymorphism and Breast Cancer Susceptibility: a Meta-Analysis Based on 9,788 Cases and 11,195 Controls.